PFIZER INC Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component
PFIZER INC (PFE) reported Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component of -$83.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent · last filed 2026-08-04
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for the quarter ending 2026-06-28 was -$83.00M.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for the quarter ending 2026-03-29 was -$72.00M.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for the quarter ending 2025-12-31 was -$345.00M, a 174.19% decline year-over-year.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for the quarter ending 2025-09-28 was -$73.00M.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for fiscal 2025 was -$678.00M, a 540.26% decline from fiscal 2024.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for fiscal 2024 was $154.00M.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for fiscal 2023 was -$610.00M.
- PFIZER INC net periodic defined benefits expense (reversal of expense), excluding service cost component for fiscal 2022 was -$849.00M.
| Period end | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 3 month | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 3 month as first filed | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 6 month | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 6 month as first filed | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 9 month | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 9 month as first filed | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 12 month | Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | -$83.00M 10-Q · filed 2026-08-04 | -$155.00M 10-Q · filed 2026-08-04 | -$500.00M derived: sum of 3 quarters · filed 2026-08-04 | -$573.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | -$72.00M 10-Q · filed 2026-05-05 | -$417.00M derived: sum of 2 quarters · filed 2026-05-05 | -$490.00M derived: sum of 3 quarters · filed 2026-05-05 | -$591.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$345.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$418.00M derived: sum of 2 quarters · filed 2026-02-26 | -$519.00M derived: sum of 3 quarters · filed 2026-08-04 | -$678.00M 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | -$73.00M 10-Q · filed 2025-11-04 | -$174.00M derived: sum of 2 quarters · filed 2026-08-04 | -$333.00M 10-Q · filed 2025-11-04 | $133.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | -$101.00M 10-Q · filed 2026-08-04 | -$260.00M 10-Q · filed 2026-08-04 | $206.00M derived: sum of 3 quarters · filed 2026-08-04 | $104.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | -$158.00M 10-Q · filed 2026-05-05 | $307.00M derived: sum of 2 quarters · filed 2026-05-05 | $205.00M derived: sum of 3 quarters · filed 2026-05-05 | $99.00M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $465.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $363.00M derived: sum of 2 quarters · filed 2026-02-26 | $257.00M derived: sum of 3 quarters · filed 2026-02-26 | $154.00M 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | -$102.00M 10-Q · filed 2025-11-04 | -$208.00M derived: sum of 2 quarters · filed 2025-11-04 | -$311.00M 10-Q · filed 2025-11-04 | -$661.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$106.00M 10-Q · filed 2025-08-05 | -$209.00M 10-Q · filed 2025-08-05 | -$559.00M derived: sum of 3 quarters · filed 2026-02-26 | -$651.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$103.00M 10-Q · filed 2025-05-05 | -$453.00M derived: sum of 2 quarters · filed 2026-02-26 | -$545.00M derived: sum of 3 quarters · filed 2026-02-26 | -$633.00M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$442.00M derived: sum of 2 quarters · filed 2026-02-26 | -$530.00M derived: sum of 3 quarters · filed 2026-02-26 | -$610.00M 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | -$92.00M 10-Q · filed 2024-11-04 | -$180.00M derived: sum of 2 quarters · filed 2024-11-04 | -$260.00M 10-Q · filed 2024-11-04 | -$815.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | -$88.00M 10-Q · filed 2024-08-05 | -$168.00M 10-Q · filed 2024-08-05 | -$723.00M derived: sum of 3 quarters · filed 2025-02-27 | -$1.03B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | -$80.00M 10-Q · filed 2024-05-08 | -$635.00M derived: sum of 2 quarters · filed 2025-02-27 | -$941.00M derived: sum of 3 quarters · filed 2025-02-27 | -$646.00M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$555.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$861.00M derived: sum of 2 quarters · filed 2025-02-27 | -$566.00M derived: sum of 3 quarters · filed 2025-02-27 | -$849.00M 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | -$306.00M 10-Q · filed 2023-11-08 | -$11.00M derived: sum of 2 quarters · filed 2023-11-08 | -$294.00M 10-Q · filed 2023-11-08 | -$1.21B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $295.00M 10-Q · filed 2023-08-09 | $12.00M 10-Q · filed 2023-08-09 | -$900.00M derived: sum of 3 quarters · filed 2024-02-22 | -$2.03B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | -$283.00M 10-Q · filed 2023-05-10 | -$1.20B derived: sum of 2 quarters · filed 2024-02-22 | -$2.33B derived: sum of 3 quarters · filed 2024-02-22 | -$2.56B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | -$912.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.04B derived: sum of 2 quarters · filed 2024-02-22 | -$2.28B derived: sum of 3 quarters · filed 2024-02-22 | -$2.55B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | -$1.13B 10-Q · filed 2022-11-09 | -$1.37B derived: sum of 2 quarters · filed 2022-11-09 | -$1.64B 10-Q · filed 2022-11-09 | -$2.07B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | -$237.00M 10-Q · filed 2022-08-10 | -$503.00M 10-Q · filed 2022-08-10 | -$941.00M derived: sum of 3 quarters · filed 2023-02-23 | $102.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | -$266.00M 10-Q · filed 2022-05-11 | -$704.00M derived: sum of 2 quarters · filed 2023-02-23 | $339.00M derived: sum of 3 quarters · filed 2023-02-23 | $148.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$438.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $605.00M derived: sum of 2 quarters · filed 2023-02-23 | $414.00M derived: sum of 3 quarters · filed 2023-02-23 | $311.00M 10-K · filed 2023-02-23 | -$236.00M 10-K · filed 2021-02-25 | |||
| 2020-09-27 | $1.04B 10-Q · filed 2021-11-12 | $54.00M 10-Q · filed 2020-11-05 | $852.00M derived: sum of 2 quarters · filed 2021-11-12 | $749.00M 10-Q · filed 2021-11-12 | -$122.00M 10-Q · filed 2020-11-05 | $1.16B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | -$191.00M 10-Q · filed 2021-08-12 | -$108.00M 10-Q · filed 2020-08-06 | -$294.00M 10-Q · filed 2021-08-12 | -$175.00M 10-Q · filed 2020-08-06 | $121.00M derived: sum of 3 quarters · filed 2022-02-24 | $102.00M derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | -$103.00M 10-Q · filed 2021-05-13 | -$67.00M 10-Q · filed 2020-05-07 | $312.00M derived: sum of 2 quarters · filed 2022-02-24 | $293.00M derived: sum of 3 quarters · filed 2022-02-24 | $242.00M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | $415.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $396.00M derived: sum of 2 quarters · filed 2022-02-24 | $345.00M derived: sum of 3 quarters · filed 2022-02-24 | $305.00M 10-K · filed 2022-02-24 | $64.00M 10-K · filed 2020-02-27 | |||
| 2019-09-29 | -$19.00M 10-Q · filed 2020-11-05 | -$70.00M derived: sum of 2 quarters · filed 2020-11-05 | -$110.00M 10-Q · filed 2020-11-05 | -$149.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$51.00M 10-Q · filed 2020-08-06 | -$91.00M 10-Q · filed 2020-08-06 | -$130.00M derived: sum of 3 quarters · filed 2021-02-25 | -$195.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$40.00M 10-Q · filed 2020-05-07 | -$79.00M derived: sum of 2 quarters · filed 2021-02-25 | -$144.00M derived: sum of 3 quarters · filed 2021-02-25 | -$228.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$104.00M derived: sum of 2 quarters · filed 2021-02-25 | -$188.00M derived: sum of 3 quarters · filed 2021-02-25 | -$270.00M 10-K · filed 2021-02-25 | -$288.00M 10-K · filed 2019-02-28 | |||
| 2018-09-30 | -$65.00M 10-Q · filed 2019-11-07 | -$149.00M derived: sum of 2 quarters · filed 2019-11-07 | -$231.00M 10-Q · filed 2019-11-07 | -$211.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | -$84.00M 10-Q · filed 2019-08-08 | -$166.00M 10-Q · filed 2019-08-08 | -$146.00M derived: sum of 3 quarters · filed 2020-02-27 | -$118.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | -$82.00M 10-Q · filed 2019-05-09 | -$62.00M derived: sum of 2 quarters · filed 2020-02-27 | -$34.00M derived: sum of 3 quarters · filed 2020-02-27 | -$42.00M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $48.00M derived: sum of 2 quarters · filed 2020-02-27 | $40.00M derived: sum of 3 quarters · filed 2020-02-27 | $101.00M 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $28.00M 10-Q · filed 2018-11-08 | $20.00M derived: sum of 2 quarters · filed 2018-11-08 | $81.00M 10-Q · filed 2018-11-08 | |||||
| 2017-07-02 | -$8.00M 10-Q · filed 2018-08-09 | $53.00M 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | $139.00M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |